“EVALUATION OF EFFICACY OF PROPHYLACTICALLY USED PREMEDICATION FOR THE MANAGEMENT OF NAUSEA, VOMITING AND HYPERSENSITIVITY REACTIONS TO CISPLATIN, TAXANES AND FAC (5-FLUOROURACIL, ADRIAMYCIN (DOXORUBICIN) AND CYCLOPHOSPHAMIDE) BASED CHEMOTHERAPY:”. 2024. Journal of Population Therapeutics and Clinical Pharmacology 31 (9): 769-76. https://doi.org/10.53555/y6s67361.